REQUEST A DEMO
Total
USD $0.00
« Back to previous page

Chile Pharma and Healthcare Sector Report 2020/2021

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: February 2020
Pages: 77
Available in: English

In a Latin American context, Chile is not a particularly large pharmaceutical and healthcare market, since its population is relatively small and healthy in terms of the incidence of communicable diseases. However, the country’s changing epidemiological profile and rapidly ageing population are allowing the sector to show grow faster than the regional average. The main drug segment, in terms of value, is that of patented drugs, although generic drugs enjoy the biggest growth opportunities. Over 2013-2018, total health expenditure rose at a CAGR of 10.9%, driven by a solid increase of government spending on healthcare. In 2018, Chile allocated 9% of its GDP to healthcare, a figure that will continue to grow in the short term. The country continues to rely on imports to meet its domestic demand for drugs. In 2013-2018, its trade deficit in pharmaceuticals widened significantly, reaching USD 1.37bn in 2018.   

 

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Chile. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in Chile
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in Chile
  • Crystallise the forces both driving and restraining this sector in Chile
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in Chile
  • Build a clear picture of trends and issues for subsectors (medical institutions, pharmaceuticals manufacturing and distribution channels)

See below for a complete table of report contents:

Chile Pharma and Healthcare Sector Report 2020/2021 - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

Chile Pharma and Healthcare Sector Report 2020/2021 -  Page 3
Chile Pharma and Healthcare Sector Report 2020/2021 -  Page 4
Chile Pharma and Healthcare Sector Report 2020/2021 -  Page 20
Chile Pharma and Healthcare Sector Report 2020/2021 -  Page 27
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?